Compare Mutual Funds

Pros
Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

5Y returns in the top 25% of the category.

5Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

Among most bought funds within the category.

Among most bought funds within the category.

Cons

-

-

INDMoney rank
4/8
2/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

10 Years 4 Months

7 Years 9 Months

Fund AUM

₹1301 Cr

₹6801 Cr

Min Investment
  1. SIP ₹100
  2. Lumpsum ₹5000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

0.69%

1.02%

Exit Load

0.25%

1%

Benchmark Index

Nifty Pharma TR INR

BSE Healthcare TR INR

No of Holdings

36

43

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(9.66%)
  2. Max Healthcare Institute Ltd Ordinary Shares(6.78%)
  3. Divi's Laboratories Ltd(5.94%)
  4. Abbott India Ltd(5.6%)
  5. HealthCare Global Enterprises Ltd(5.04%)
  1. Sun Pharmaceuticals Industries Ltd(11.21%)
  2. Cipla Ltd(9.4%)
  3. Mankind Pharma Ltd(7.64%)
  4. Dr Reddy's Laboratories Ltd(6.52%)
  5. Biocon Ltd(6.2%)
No of Sectors

2

2

Top 3 Sectors
  1. Health(96.58%)
  2. Basic Materials(3.42%)
  1. Health(98.81%)
  2. Basic Materials(1.19%)
Equity %

97.59%

97.98%

Debt %

-

-

P/E

41.15

32.15

P/B

6.83

3.94

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

-2.61%

-1.31%

3-Month Return

-2.59%

-4.79%

6-Month Return

-5.64%

-7.86%

1-Year Return

5.33%

6.31%

3-Year Return

25.03%

28.52%

5-Year Return

17.51%

18.82%

Sharpe

1.13

1.3

Alpha

1

2.27

Beta

0.95

0.94

Standard Deviation

16.16

15.86

Information Ratio

0.04

0.44

Description

Tata India Pharma & Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Rajat Srivastava

Sharmila D’mello, Dharmesh Kakkad

Most Popular Comparisons